Cargando…
Optimal design of cluster randomised trials with continuous recruitment and prospective baseline period
BACKGROUND: Cluster randomised trials, like individually randomised trials, may benefit from a baseline period of data collection. We consider trials in which clusters prospectively recruit or identify participants as a continuous process over a given calendar period, and ask whether and for how lon...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010895/ https://www.ncbi.nlm.nih.gov/pubmed/33685241 http://dx.doi.org/10.1177/1740774520976564 |
_version_ | 1783673150580457472 |
---|---|
author | Hooper, Richard Copas, Andrew J |
author_facet | Hooper, Richard Copas, Andrew J |
author_sort | Hooper, Richard |
collection | PubMed |
description | BACKGROUND: Cluster randomised trials, like individually randomised trials, may benefit from a baseline period of data collection. We consider trials in which clusters prospectively recruit or identify participants as a continuous process over a given calendar period, and ask whether and for how long investigators should collect baseline data as part of the trial, in order to maximise precision. METHODS: We show how to calculate and plot the variance of the treatment effect estimator for different lengths of baseline period in a range of scenarios, and offer general advice. RESULTS: In some circumstances it is optimal not to include a baseline, while in others there is an optimal duration for the baseline. All other things being equal, the circumstances where it is preferable not to include a baseline period are those with a smaller recruitment rate, smaller intracluster correlation, greater decay in the intracluster correlation over time, or wider transition period between recruitment under control and intervention conditions. CONCLUSION: The variance of the treatment effect estimator can be calculated numerically, and plotted against the duration of baseline to inform design. It would be of interest to extend these investigations to cluster randomised trial designs with more than two randomised sequences of control and intervention condition, including stepped wedge designs. |
format | Online Article Text |
id | pubmed-8010895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-80108952021-04-08 Optimal design of cluster randomised trials with continuous recruitment and prospective baseline period Hooper, Richard Copas, Andrew J Clin Trials Articles BACKGROUND: Cluster randomised trials, like individually randomised trials, may benefit from a baseline period of data collection. We consider trials in which clusters prospectively recruit or identify participants as a continuous process over a given calendar period, and ask whether and for how long investigators should collect baseline data as part of the trial, in order to maximise precision. METHODS: We show how to calculate and plot the variance of the treatment effect estimator for different lengths of baseline period in a range of scenarios, and offer general advice. RESULTS: In some circumstances it is optimal not to include a baseline, while in others there is an optimal duration for the baseline. All other things being equal, the circumstances where it is preferable not to include a baseline period are those with a smaller recruitment rate, smaller intracluster correlation, greater decay in the intracluster correlation over time, or wider transition period between recruitment under control and intervention conditions. CONCLUSION: The variance of the treatment effect estimator can be calculated numerically, and plotted against the duration of baseline to inform design. It would be of interest to extend these investigations to cluster randomised trial designs with more than two randomised sequences of control and intervention condition, including stepped wedge designs. SAGE Publications 2021-03-08 2021-04 /pmc/articles/PMC8010895/ /pubmed/33685241 http://dx.doi.org/10.1177/1740774520976564 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Articles Hooper, Richard Copas, Andrew J Optimal design of cluster randomised trials with continuous recruitment and prospective baseline period |
title | Optimal design of cluster randomised trials with continuous recruitment and prospective baseline period |
title_full | Optimal design of cluster randomised trials with continuous recruitment and prospective baseline period |
title_fullStr | Optimal design of cluster randomised trials with continuous recruitment and prospective baseline period |
title_full_unstemmed | Optimal design of cluster randomised trials with continuous recruitment and prospective baseline period |
title_short | Optimal design of cluster randomised trials with continuous recruitment and prospective baseline period |
title_sort | optimal design of cluster randomised trials with continuous recruitment and prospective baseline period |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010895/ https://www.ncbi.nlm.nih.gov/pubmed/33685241 http://dx.doi.org/10.1177/1740774520976564 |
work_keys_str_mv | AT hooperrichard optimaldesignofclusterrandomisedtrialswithcontinuousrecruitmentandprospectivebaselineperiod AT copasandrewj optimaldesignofclusterrandomisedtrialswithcontinuousrecruitmentandprospectivebaselineperiod |